Abstract
We have investigated the frequencies of RFLPs of the apolipoprotein (apo) AII gene and of the apo AI-CIII-AIV gene cluster in 109 men, selected from a random sample of 1,910 men aged 45-59 years, to cover a wide range of plasma high-density-lipoprotein (HDL)-cholesterol concentration. There was no significant difference in apo AI or apo AII RFLP allele frequency between groups of individuals with high and low HDL-cholesterol concentration. However, the apo AI PstI RFLP showed an association with genetic variation determining the plasma concentration of apo AI in this sample. Genetic variation in the apo AI-CIII-AIV gene region, as defined by haplotypes, accounted for 16% of the phenotypic variance in the apo AI concentration and for 8% of the phenotypic variance in HDL-cholesterol concentration. There was no significant association between alleles of the apo AII MspI RFLP and genetic variation determining apo AII or HDL concentration. The data demonstrate that genetic variation in the apo AI-CIII-AIV gene cluster is involved in determining the serum concentration of apo AI in this sample of clinically well individuals.
Full text
PDFImages in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berg K., Borresen A. L. Serum-high-density-lipoprotein and atherosclerotic heart-disease. Lancet. 1976 Mar 6;1(7958):499–501. doi: 10.1016/s0140-6736(76)90291-9. [DOI] [PubMed] [Google Scholar]
- Cheung P., Kao F. T., Law M. L., Jones C., Puck T. T., Chan L. Localization of the structural gene for human apolipoprotein A-I on the long arm of human chromosome 11. Proc Natl Acad Sci U S A. 1984 Jan;81(2):508–511. doi: 10.1073/pnas.81.2.508. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Coleman R. T., Gonzalez P. A., Funke H., Assmann G., Levy-Wilson B., Frossard P. M. Polymorphisms in the apolipoprotein AI-CIII gene complex. Mol Biol Med. 1986 Jun;3(3):213–228. [PubMed] [Google Scholar]
- Fager G., Wiklund O., Olofsson S. O., Wilhelmsen L., Bondjers G. Multivariate analyses of serum apolipoproteins and risk factors in relation to acute myocardial infarction. Arteriosclerosis. 1981 Jul-Aug;1(4):273–279. doi: 10.1161/01.atv.1.4.273. [DOI] [PubMed] [Google Scholar]
- Gordon T., Castelli W. P., Hjortland M. C., Kannel W. B., Dawber T. R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977 May;62(5):707–714. doi: 10.1016/0002-9343(77)90874-9. [DOI] [PubMed] [Google Scholar]
- Jahn C. E., Osborne J. C., Jr, Schaefer E. J., Brewer H. B., Jr In vitro activation of the enzymic activity of hepatic lipase by apoA-II. FEBS Lett. 1981 Aug 31;131(2):366–368. doi: 10.1016/0014-5793(81)80405-x. [DOI] [PubMed] [Google Scholar]
- Jeffreys A. J. DNA sequence variants in the G gamma-, A gamma-, delta- and beta-globin genes of man. Cell. 1979 Sep;18(1):1–10. doi: 10.1016/0092-8674(79)90348-9. [DOI] [PubMed] [Google Scholar]
- Karathanasis S. K. Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes. Proc Natl Acad Sci U S A. 1985 Oct;82(19):6374–6378. doi: 10.1073/pnas.82.19.6374. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kessling A. M., Berg K., Mockleby E., Humphries S. E. DNA polymorphisms around the apo AI gene in normal and hyperlipidaemic individuals selected for a twin study. Clin Genet. 1986 Jun;29(6):485–490. doi: 10.1111/j.1399-0004.1986.tb00548.x. [DOI] [PubMed] [Google Scholar]
- Kessling A. M., Horsthemke B., Humphries S. E. A study of DNA polymorphisms around the human apolipoprotein AI gene in hyperlipidaemic and normal individuals. Clin Genet. 1985 Oct;28(4):296–306. doi: 10.1111/j.1399-0004.1985.tb00403.x. [DOI] [PubMed] [Google Scholar]
- Knott T. J., Eddy R. L., Robertson M. E., Priestley L. M., Scott J., Shows T. B. Chromosomal localization of the human apoprotein CI gene and of a polymorphic apoprotein AII gene. Biochem Biophys Res Commun. 1984 Nov 30;125(1):299–306. doi: 10.1016/s0006-291x(84)80368-x. [DOI] [PubMed] [Google Scholar]
- Lackner K. J., Law S. W., Brewer H. B., Jr, Sakaguchi A. Y., Naylor S. L. The human apolipoprotein A-II gene is located on chromosome 1. Biochem Biophys Res Commun. 1984 Aug 16;122(3):877–883. doi: 10.1016/0006-291x(84)91172-0. [DOI] [PubMed] [Google Scholar]
- Maciejko J. J., Holmes D. R., Kottke B. A., Zinsmeister A. R., Dinh D. M., Mao S. J. Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease. N Engl J Med. 1983 Aug 18;309(7):385–389. doi: 10.1056/NEJM198308183090701. [DOI] [PubMed] [Google Scholar]
- Miller N. E., Thelle D. S., Forde O. H., Mjos O. D. The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study. Lancet. 1977 May 7;1(8019):965–968. doi: 10.1016/s0140-6736(77)92274-7. [DOI] [PubMed] [Google Scholar]
- Myers R. M., Tilly K., Maniatis T. Fine structure genetic analysis of a beta-globin promoter. Science. 1986 May 2;232(4750):613–618. doi: 10.1126/science.3457470. [DOI] [PubMed] [Google Scholar]
- Ordovas J. M., Schaefer E. J., Salem D., Ward R. H., Glueck C. J., Vergani C., Wilson P. W., Karathanasis S. K. Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia. N Engl J Med. 1986 Mar 13;314(11):671–677. doi: 10.1056/NEJM198603133141102. [DOI] [PubMed] [Google Scholar]
- Rees A., Shoulders C. C., Stocks J., Galton D. J., Baralle F. E. DNA polymorphism adjacent to human apoprotein A-1 gene: relation to hypertriglyceridaemia. Lancet. 1983 Feb 26;1(8322):444–446. doi: 10.1016/s0140-6736(83)91440-x. [DOI] [PubMed] [Google Scholar]
- Rees A., Stocks J., Sharpe C. R., Vella M. A., Shoulders C. C., Katz J., Jowett N. I., Baralle F. E., Galton D. J. Deoxyribonucleic acid polymorphism in the apolipoprotein A-1-C-III gene cluster. Association with hypertriglyceridemia. J Clin Invest. 1985 Sep;76(3):1090–1095. doi: 10.1172/JCI112062. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schaefer E. J., Eisenberg S., Levy R. I. Lipoprotein apoprotein metabolism. J Lipid Res. 1978 Aug;19(6):667–687. [PubMed] [Google Scholar]
- Scott J., Knott T. J., Priestley L. M., Robertson M. E., Mann D. V., Kostner G., Miller G. J., Miller N. E. High-density lipoprotein composition is altered by a common DNA polymorphism adjacent to apoprotein AII gene in man. Lancet. 1985 Apr 6;1(8432):771–773. doi: 10.1016/s0140-6736(85)91443-6. [DOI] [PubMed] [Google Scholar]
- Sing C. F., Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet. 1985 Mar;37(2):268–285. [PMC free article] [PubMed] [Google Scholar]
- Utermann G., Kindermann I., Kaffarnik H., Steinmetz A. Apolipoprotein E phenotypes and hyperlipidemia. Hum Genet. 1984;65(3):232–236. doi: 10.1007/BF00286508. [DOI] [PubMed] [Google Scholar]
- Warnick G. R., Albers J. J. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res. 1978 Jan;19(1):65–76. [PubMed] [Google Scholar]
- Yaari S., Goldbourt, Even-Zohar S., Neufeld H. N. Associations of serum high density lipoprotein and total cholesterol with total, cardiovascular, and cancer mortality in a 7-year prospective study of 10 000 men. Lancet. 1981 May 9;1(8228):1011–1015. doi: 10.1016/s0140-6736(81)92184-x. [DOI] [PubMed] [Google Scholar]